O
Omegga
Omegga develops an optical, non-invasive solution for the in-ovo sexing of chicken embryos before incubation day 7
About Omegga
Omegga GmbH is a pioneering startup focused on revolutionizing the poultry industry through innovative technology. The company specializes in developing a non-invasive, optical, and AI-powered method for early sex detection of chicken embryos. This technology allows hatcheries to determine the sex of chicken embryos by the 7th day of incubation, well before the embryos develop pain perception. This early detection is crucial for improving efficiency and sustainability in egg-laying farms.
Read full description
Omegga's primary clients are commercial hatcheries and egg-laying farms that are looking for cost-effective and scalable solutions to enhance their operations. The company operates in the agricultural technology market, specifically targeting the poultry sector, which faces significant challenges related to the ethical and economic implications of male chick culling.
The business model of Omegga involves the sale and integration of its proprietary hardware and software solutions into existing incubation infrastructure. This "plug and play" integration makes it easy for hatcheries to adopt the technology without significant modifications to their current systems. Omegga generates revenue through the sale of its hardware, as well as potential subscription fees for ongoing software updates and AI improvements.
Omegga's technology not only helps in early sex detection but also allows for the repurposing of male chicks into new revenue streams, thereby increasing overall efficiency. By using light to scan the embryonated eggs, the method is non-invasive, cost-effective, and scalable, addressing a significant gap in the market where no ideal solution currently exists.
In summary, Omegga offers a sustainable and economically viable solution that aligns with evolving legal regulations and consumer preferences, making it a promising player in the poultry industry.
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Munich, Germany
- Employees
- 26
- Open positions
- 4
- Dealroom signal
- 87.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Medical Research, EIC, EIC Fund, Hard Tech, Woman Founder, Horizon Europe, DT and LS, science-based
Latest news
Press, funding announcements and product moves mentioning Omegga.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jun 2026 | $11M | $44M | IQ Capital · EIC Fund · Capnamic Ventures | ↗ |
| EARLY VC✓Equity / VC | Nov 2023 | $0 | — | EIC Fund | — |
Growth signals
Latest recorded traffic for Omegga is 2.3K monthly website visits, up 369.4% over the last three months. Omegga's team grew 62.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
stealth
European Innovation Council
IQ Capital
Capnamic Ventures
Series A2 investors entered at this stage
Rockstart
EIC Fund
Other known investors1 additional known investor
Strascheg Center for Entrepreneurship (SCE)
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Omegga on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Omegga’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







